Pervasive stigma around cannabis use is leading some ER doctors to overdiagnose a rare marijuana-related syndrome.

Overview of Short Bowel Syndrome MarketThe Global Short Bowel Syndrome Market is valued at USD 1.76 Billion in 2024 and is projected to attain a value of USD 3.66 Billion by 2035 at a CAGR of 6.91% ...

After a season of regulatory upheaval, obesity and rare genetic diseases will likely remain major themes for biopharma in ...

An instructor of medicine is concerned cannabis hyperemesis syndrome (CHS) is being diagnosed too often without a proper ...

Cox, who has almost 37,000 followers on Instagram, posted about the 'annoying' exchange with a GP that took place last week.

A leading vascular surgeon is angry and frustrated that patients like Amelia Turner are told their symptoms are eating ...

A new study published in the journal Diabetes, Obesity and Metabolism has found that cannabidiol (CBD) significantly improves metabolic health and reduces inflammation and liver fibrosis in a mouse ...

Chronic fatigue syndrome. Read the latest research news on chronic fatigue syndrome (CFS).

Novartis is set to launch its one-off gene therapy Zolgensma for the ultra-rare muscle-wasting disease spinal muscular atrophy (SMA) in Germany at the start of July priced at 1,945,000 euros, and ...

An estimated 10-15 percent of American adults suffer from irritable bowel syndrome (IBS). Proper diagnosis from a medical professional is important for getting effective treatment and relief.